These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Treatment of myelodysplastic syndromes with hematopoietic growth factors. Ganser A; Hoelzer D Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194 [TBL] [Abstract][Full Text] [Related]
26. Hematopoietic growth factors: overview and clinical applications, Part III. Robinson BE; Quesenberry PJ Am J Med Sci; 1990 Nov; 300(5):311-21. PubMed ID: 1700606 [TBL] [Abstract][Full Text] [Related]
27. [Current status of the clinical application of hematopoietic growth factors in oncology]. Karthaus M; Ganser A Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692 [TBL] [Abstract][Full Text] [Related]
28. Allogeneic marrow transplantation and the use of hematopoietic growth factors. Appelbaum FR Stem Cells; 1995 Jul; 13(4):344-50. PubMed ID: 7549892 [TBL] [Abstract][Full Text] [Related]
29. Haematopoietic growth factors and their therapeutic use. Wadhwa M; Thorpe R Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415 [TBL] [Abstract][Full Text] [Related]
30. Actions of molecules which regulate hemopoiesis on endothelial cells: memoirs of common ancestors? Bussolino F; Bocchietto E; Silvagno F; Soldi R; Arese M; Mantovani A Pathol Res Pract; 1994 Oct; 190(9-10):834-9. PubMed ID: 7534912 [TBL] [Abstract][Full Text] [Related]
31. Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells. Bussolino F; Colotta F; Bocchietto E; Guglielmetti A; Mantovani A Int J Clin Lab Res; 1993; 23(1):8-12. PubMed ID: 7682862 [TBL] [Abstract][Full Text] [Related]
32. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Möhle R; Kanz L Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183 [TBL] [Abstract][Full Text] [Related]
33. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells. Herrmann F; Brugger W; Kanz L; Mertelsmann R Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732 [No Abstract] [Full Text] [Related]
34. The sources and actions of the human colony stimulating factors. Sieff CA Mead Johnson Symp Perinat Dev Med; 1988; (32):21-7. PubMed ID: 2485454 [No Abstract] [Full Text] [Related]
35. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)]. Motoyoshi K Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240 [TBL] [Abstract][Full Text] [Related]
37. Haematopoietic growth factors and cancer therapy. Sheridan WP; Fox RM Med J Aust; 1993 Apr; 158(8):514-6. PubMed ID: 7683743 [No Abstract] [Full Text] [Related]
38. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes. Hast R; Eriksson M; Jakovleva K Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516 [No Abstract] [Full Text] [Related]
39. [Hematopoietic growth factors. Therapeutic value in oncology]. Archimbaud E; Fiere D Presse Med; 1993 Apr; 22(12):585-90. PubMed ID: 7685525 [TBL] [Abstract][Full Text] [Related]
40. Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors. Chatta GS; Dale DC Drugs Aging; 1996 Jul; 9(1):37-47. PubMed ID: 8818584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]